Thrombus formation in a HeartMate II

Mokadam, Nahush A.; Andrus, Shauna; Ungerleider, Amy
March 2011
European Journal of Cardio-Thoracic Surgery;Mar2011, Vol. 39 Issue 3, p414
Academic Journal
No abstract available.


Related Articles

  • A Successful Anticoagulation Protocol for the First HeartMate II Implantation in the United States. Amir, Offer; Bracey, Arthur W.; Smart, Frank W.; Delgado III, Reynolds M.; Shah, Nyma; Kar, Biswajit // Texas Heart Institute Journal;2005, Vol. 32 Issue 3, p399 

    Bleeding and thrombus formation are common problems with life-threatening implications in patients receiving a left ventricular assist device. We describe the anticoagulation protocol for the 1st patient in the United States to undergo successful implantation of the HeartMate® II left...

  • Reliability of the Thoratec HeartMate II flow measurements and alarms in the presence of reduced or non-existent flow. Hall, Seana G.; Gardner, Kayla; Larson, Douglas F.; Smith, Richard // Perfusion;Mar2016, Vol. 31 Issue 2, p111 

    Introduction: The Thoratec Corporation has over 10,000 patients registered as recipients of the HeartMate II left ventricular assist device (LVAD) worldwide. Although it has undoubtedly prolonged the lifespan of heart failure patients, the most recognized risk associated with these devices is...

  • Patient Logs One Year on Heart Pump. Zipes, Douglas // Medical Update;2004, Vol. 30 Issue 6, p4 

    Focuses on the implantation of HeartMate II, an alternative for heart transplant, on student Everardo Flores at the Texas Heart Institute in Houston, Texas. Benefits of the HeartMate II to patients with heart failure.

  • Spectrum introducing latest generation heart pumps. SLOWIK, ELIZABETH // Grand Rapids Business Journal;11/22/2010, Vol. 28 Issue 48, p13 

    The article previews the HeartMate II left ventricle assistance device (LVAD) from Spectrum Health.

  • Post-approval study confirms improved survival with HeartMate II LVAD. Dellapena, Deb // Cardiology Today;Jun2013, Vol. 16 Issue 6, p17 

    The article highlights findings of a post-approval study on the use of the HeartMate II Left Ventricular Assist Device.

  • HeartMate II offers small size, applicability to more patients. Raible, Eric // Cardiology Today;Jun2008, Vol. 11 Issue 6, p24 

    The article evaluates the HeartMate II LV assist system from Thoratec Corporation.

  • HeartMate II approval offers heart therapy for women, small men. Yoffee, Lynn // Biomedical Business & Technology;May2008, Vol. 31 Issue 5, p34 

    The article offers information on the HeartMate II Left Ventricular Assist System (LVAS) from Thoratec.

  • Infectious complications in patients with ventricular assist device HeartMate II. Konarik, M.; Szarszoi, O.; Netuka, I.; Maly, J.; Pirk, J.; Urban, M. // Journal of Cardiothoracic Surgery;2013, Vol. 8 Issue Suppl 1, p1 

    An abstract of the article "Infectious complications in patients with ventricular assist device HeartMate II" by M. Konarik and colleagues is presented.

  • Ventricular assist system available for destination therapy.  // Critical Care Nurse;Aug2010, Vol. 30 Issue 4, p85 

    The article evaluates the HeartMate II left ventricular assist system (LVAS) for destination therapy from Thoratec Corp.

  • Aortic Valve Noncoronary Cusp Thrombosis. Demirozu, Zumrut T.; Frazier, O. H. // Texas Heart Institute Journal;2012, Vol. 39 Issue 5, p618 

    Different institutions have different strategies for managing both native and prosthetic aortic valves in recipients of left ventricular assist devices (LVADs). Anticoagulation protocols and pump-flow algorithms remain nonstandardized. We describe our institutional experience with thrombotic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics